547 related articles for article (PubMed ID: 33381121)
1. Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota.
Fidelle M; Yonekura S; Picard M; Cogdill A; Hollebecque A; Roberti MP; Zitvogel L
Front Immunol; 2020; 11():600886. PubMed ID: 33381121
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.
Roberti MP; Yonekura S; Duong CPM; Picard M; Ferrere G; Tidjani Alou M; Rauber C; Iebba V; Lehmann CHK; Amon L; Dudziak D; Derosa L; Routy B; Flament C; Richard C; Daillère R; Fluckiger A; Van Seuningen I; Chamaillard M; Vincent A; Kourula S; Opolon P; Ly P; Pizzato E; Becharef S; Paillet J; Klein C; Marliot F; Pietrantonio F; Benoist S; Scoazec JY; Dartigues P; Hollebecque A; Malka D; Pagès F; Galon J; Gomperts Boneca I; Lepage P; Ryffel B; Raoult D; Eggermont A; Vanden Berghe T; Ghiringhelli F; Vandenabeele P; Kroemer G; Zitvogel L
Nat Med; 2020 Jun; 26(6):919-931. PubMed ID: 32451498
[TBL] [Abstract][Full Text] [Related]
3. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
4. Turning tolerogenic into immunogenic ileal cell death through ileal microbiota: the key to unlock the mystery of colon cancer immunoscore?
Roberti MP; Picard M; Yonekura S; Zitvogel L
Oncoimmunology; 2020 Jun; 9(1):1778834. PubMed ID: 32923141
[TBL] [Abstract][Full Text] [Related]
5. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers.
Kikuchi T; Mimura K; Ashizawa M; Okayama H; Endo E; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Shimada K; Yoshimura K; Tsunoda T; Kono K
Cancer Immunol Immunother; 2020 Jan; 69(1):23-32. PubMed ID: 31768581
[TBL] [Abstract][Full Text] [Related]
6. Crypt- and Mucosa-Associated Core Microbiotas in Humans and Their Alteration in Colon Cancer Patients.
Saffarian A; Mulet C; Regnault B; Amiot A; Tran-Van-Nhieu J; Ravel J; Sobhani I; Sansonetti PJ; Pédron T
mBio; 2019 Jul; 10(4):. PubMed ID: 31311881
[TBL] [Abstract][Full Text] [Related]
7. Predictive values of colon microbiota in the treatment response to colorectal cancer.
Galan-Ros J; Ramos-Arenas V; Conesa-Zamora P
Pharmacogenomics; 2020 Sep; 21(14):1045-1059. PubMed ID: 32896201
[TBL] [Abstract][Full Text] [Related]
8. SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion.
Lu C; Yang D; Klement JD; Oh IK; Savage NM; Waller JL; Colby AH; Grinstaff MW; Oberlies NH; Pearce CJ; Xie Z; Kulp SK; Coss CC; Phelps MA; Albers T; Lebedyeva IO; Liu K
Cancer Immunol Res; 2019 Mar; 7(3):414-427. PubMed ID: 30610059
[TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
[TBL] [Abstract][Full Text] [Related]
10. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer.
Overacre-Delgoffe AE; Bumgarner HJ; Cillo AR; Burr AHP; Tometich JT; Bhattacharjee A; Bruno TC; Vignali DAA; Hand TW
Immunity; 2021 Dec; 54(12):2812-2824.e4. PubMed ID: 34861182
[TBL] [Abstract][Full Text] [Related]
11. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
[TBL] [Abstract][Full Text] [Related]
12. Microbiome Conundrum in Colon Cancer: Development, Progression, and Therapeutics.
Malla RR
Crit Rev Oncog; 2020; 25(2):129-139. PubMed ID: 33389862
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Role of Gut Microbiome in Colon Cancer.
Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S
Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
Front Immunol; 2021; 12():778329. PubMed ID: 34975867
[TBL] [Abstract][Full Text] [Related]
16. Impact of the ileal microbiota on colon cancer.
Roberti MP; Rauber C; Kroemer G; Zitvogel L
Semin Cancer Biol; 2022 Nov; 86(Pt 2):955-966. PubMed ID: 34624451
[TBL] [Abstract][Full Text] [Related]
17. Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.
Lavoie S; Chun E; Bae S; Brennan CA; Gallini Comeau CA; Lang JK; Michaud M; Hoveyda HR; Fraser GL; Fuller MH; Layden BT; Glickman JN; Garrett WS
Gastroenterology; 2020 Apr; 158(5):1359-1372.e9. PubMed ID: 31917258
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic cell death in colon cancer prevention and therapy.
Ruan H; Leibowitz BJ; Zhang L; Yu J
Mol Carcinog; 2020 Jul; 59(7):783-793. PubMed ID: 32215970
[TBL] [Abstract][Full Text] [Related]
19. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
[TBL] [Abstract][Full Text] [Related]
20. Combination Immunotherapy With LIGHT and Interleukin-2 Increases CD8 Central Memory T-Cells In Vivo.
Fernandez MF; Qiao G; Tulla K; Prabhakar BS; Maker AV
J Surg Res; 2021 Jul; 263():44-52. PubMed ID: 33631377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
